Abstract: Vaccine compositions including one or more antigens and one or more integrin agonists or activating compounds present in an amount sufficient to increase an immune response of a patient to the one or more antigens.
Type:
Grant
Filed:
July 3, 2020
Date of Patent:
April 26, 2022
Assignee:
7 Hills Pharma Inc. and Texas Heart Institute
Inventors:
Darren G. Woodside, Peter Vanderslice, Upendra K. Marathi